在中国人群中,从多个吸入器设备转换COPD三重吸入器治疗到单个吸入器设备的前性随机研究
Wang Chun Kwok1, Ting Fung Ma2, Chung Ki Tsui1
1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|December 16, 2024
概括
在患有慢性阻塞性肺病 (COPD) 的中国患者中,从多次吸入器三重疗法 (MITT) 转换为单次吸入器三重疗法 (SITT),导致吸入器错误减少,药物坚持改善. 这表明SITT可能是一个有益的替代方案来管理COPD在这个人群.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 建议在COPD患者中进行三重治疗 (吸入性皮质类固醇和双重支气管扩展剂),包括恶化和eosinophilia.
- 给药选择包括单吸入器三重疗法 (SITT) 和多吸入器三重疗法 (MITT).
- 证据表明SITT对MITT的益处有限,特别是在中国人群中从MITT切换到SITT,是有限的.
研究的目的:
- 在中国的COPD患者中,研究从MITT切换到SITT的影响.
- 为了评估吸入器的关键错误,呼吸障碍 (mMRC尺度),药物坚持 (MARS-A) 和患者满意度.
主要方法:
- 一个开放的,双臂的临床试验,涉及70名中国COPD患者.
- 患者从现有的MITT疗法转换为SITT.
- 评估结果包括吸入器错误,mMRC呼吸障碍量表,MARS-A评分和满意度评分.
主要成果:
- 与MITT组相比,SITT组在第一次和第二次访问时显示出相对较少的临界吸入器错误 (分别为p=0.038和p=0.007).
- 切换到SITT的患者在喘 (MARS-A) 药物坚持报告尺度 (MARS-A) 得分 (+3.76±7.48) 中显著增加,而在MITT组 (-1.27±7.76) (p=0.008) 中出现下降.
- 与MITT组 (24.2%) 相比,SITT组的患者比例更高 (59.5%),与SITT (p=0.007) 相比,调整后的几率比率为6.23.
结论:
- 在中国的COPD患者中,从MITT切换到SITT与严重的吸入器错误的减少有关.
- 与MITT相比,SITT表现出更好的药物坚持,这是MARS-A得分更高的迹象.
- 这些发现表明SITT对MITT在中国人群中治疗COPD的潜在好处.
相关概念视频
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K